General Information of Drug Off-Target (DOT) (ID: OTMRLWGT)

DOT Name Axin interactor, dorsalization-associated protein (AIDA)
Synonyms Axin interaction partner and dorsalization antagonist
Gene Name AIDA
Related Disease
Myocardial infarction ( )
Obesity ( )
Promyelocytic leukaemia ( )
Pneumonia ( )
Coronary atherosclerosis ( )
Coronary heart disease ( )
UniProt ID
AIDA_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF14186 ; PF08910
Sequence
MSEVTRSLLQRWGASFRRGADFDSWGQLVEAIDEYQILARHLQKEAQAQHNNSEFTEEQK
KTIGKIATCLELRSAALQSTQSQEEFKLEDLKKLEPILKNILTYNKEFPFDVQPVPLRRI
LAPGEEENLEFEEDEEEGGAGAGSPDSFPARVPGTLLPRLPSEPGMTLLTIRIEKIGLKD
AGQCIDPYITVSVKDLNGIDLTPVQDTPVASRKEDTYVHFNVDIELQKHVEKLTKGAAIF
FEFKHYKPKKRFTSTKCFAFMEMDEIKPGPIVIELYKKPTDFKRKKLQLLTKKPLYLHLH
QTLHKE
Function
Acts as a ventralizing factor during embryogenesis. Inhibits axin-mediated JNK activation by binding axin and disrupting axin homodimerization. This in turn antagonizes a Wnt/beta-catenin-independent dorsalization pathway activated by AXIN/JNK-signaling.
Tissue Specificity Widely expressed in adult tissues, with highest expression in the heart and skeletal muscle.

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Myocardial infarction DIS655KI Strong Biomarker [1]
Obesity DIS47Y1K Strong Biomarker [2]
Promyelocytic leukaemia DISYGG13 Strong Biomarker [3]
Pneumonia DIS8EF3M Disputed Biomarker [4]
Coronary atherosclerosis DISKNDYU Limited Biomarker [5]
Coronary heart disease DIS5OIP1 Limited Altered Expression [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Axin interactor, dorsalization-associated protein (AIDA). [6]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Axin interactor, dorsalization-associated protein (AIDA). [7]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Axin interactor, dorsalization-associated protein (AIDA). [8]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of Axin interactor, dorsalization-associated protein (AIDA). [9]
chloropicrin DMSGBQA Investigative chloropicrin increases the expression of Axin interactor, dorsalization-associated protein (AIDA). [10]
[3H]methyltrienolone DMTSGOW Investigative [3H]methyltrienolone increases the expression of Axin interactor, dorsalization-associated protein (AIDA). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction.JACC Cardiovasc Imaging. 2018 Oct;11(10):1433-1444. doi: 10.1016/j.jcmg.2017.11.034. Epub 2018 Feb 14.
2 AIDA Selectively Mediates Downregulation of Fat Synthesis Enzymes by ERAD to Retard Intestinal Fat Absorption and Prevent Obesity.Cell Metab. 2018 Apr 3;27(4):843-853.e6. doi: 10.1016/j.cmet.2018.02.021.
3 AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.Blood. 2011 May 5;117(18):4716-25. doi: 10.1182/blood-2010-08-302950. Epub 2011 Mar 8.
4 Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii.Front Microbiol. 2018 Dec 17;9:3105. doi: 10.3389/fmicb.2018.03105. eCollection 2018.
5 Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene.Genome Biol. 2019 Jul 8;20(1):133. doi: 10.1186/s13059-019-1749-5.
6 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
7 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
8 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
9 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
10 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
11 Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics. 2006 Sep 29;7:246. doi: 10.1186/1471-2164-7-246.